Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-23 Sale | 2023-01-25 6:04 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 6,843 | $35.66 | $244,021 | 59,753 (Direct) | View |
| 2023-01-13 Sale | 2023-01-18 5:58 pm | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 29,000 | $37.18 | $1,078,261 | 558,853 (Direct) | View |
| 2023-01-09 Sale | 2023-01-11 7:09 pm | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 60,000 | $34.82 | $2,089,472 | 639,377 (Direct) | View |
| 2022-12-20 Sale | 2022-12-22 4:42 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 16,926 | $29.15 | $493,398 | 105,768 (Direct) | View |
| 2022-12-15 Sale | 2022-12-19 7:22 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 1,597 | $28.37 | $45,311 | 124,591 (Direct) | View |
| 2022-12-12 Sale | 2022-12-14 8:56 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 16,256 | $28.12 | $457,077 | 142,144 (Direct) | View |
| 2022-11-15 Sale | 2022-11-16 6:45 pm | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 8,125 | $22.05 | $179,156 | 21,875 (Direct) | View |
| 2022-08-17 Purchase | 2022-08-19 4:32 pm | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. See Remarks 10% Owner | 425,531 | $23.5 | $9,999,979 | 1,369,623 (Indirect) | View |
| 2022-06-01 Sale | 2022-06-02 5:29 pm | Viridian Therapeutics Inc. | VRDN | Violin Jonathan Chief Executive Officer | 30,000 | $12.2 | $366,000 | 480,905 (Direct) | View |
| 2022-05-02 Sale | 2022-05-04 5:23 pm | Viridian Therapeutics Inc. | VRDN | Violin Jonathan Chief Executive Officer | 30,000 | $13.04 | $391,200 | 510,905 (Direct) | View |
| 2022-04-01 Sale | 2022-04-05 6:09 pm | Viridian Therapeutics Inc. | VRDN | Violin Jonathan Chief Executive Officer | 30,000 | $18.92 | $567,636 | 540,905 (Direct) | View |
| 2022-03-01 Sale | 2022-03-03 4:48 pm | Viridian Therapeutics Inc. | VRDN | Violin Jonathan Chief Executive Officer | 30,000 | $17.65 | $529,491 | 570,905 (Direct) | View |
| 2022-02-01 Sale | 2022-02-03 6:11 pm | Viridian Therapeutics Inc. | VRDN | Violin Jonathan Chief Executive Officer | 30,000 | $19.09 | $572,818 | 880,905 (Direct) | View |
| 2021-09-23 Purchase | 2021-09-28 7:46 pm | Viridian Therapeutics Inc. | VRDN | Frazier Life Sciences Public Fund L.P. FHMLSP L.P. FHMLSP L.L.C. 10% Owner | 200,000 | $11 | $2,200,000 | 1,505,200 (Direct) | View |
| 2021-09-21 Purchase | 2021-09-23 09:30 am | Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Director 10% Owner | 909,000 | $11 | $9,999,000 | 1,077,283 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-23 Exercise | 2023-01-25 6:04 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 4,971 | $23.03 | 59,753 (Direct) | View |
| 2023-01-23 Exercise | 2023-01-25 6:04 pm | N/A 2031-01-18 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 6,843 | $0 | 59,753 (Direct) | View |
| 2023-01-23 Exercise | 2023-01-25 6:04 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 1,872 | $14 | 59,753 (Direct) | View |
| 2023-01-13 Exercise | 2023-01-18 5:58 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 29,000 | $23.03 | 558,853 (Direct) | View |
| 2023-01-13 Exercise | 2023-01-18 5:58 pm | N/A 2031-01-17 | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 29,000 | $0 | 558,853 (Direct) | View |
| 2023-01-09 Exercise | 2023-01-11 7:09 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 60,000 | $23.03 | 639,377 (Direct) | View |
| 2023-01-09 Exercise | 2023-01-11 7:09 pm | N/A 2031-01-17 | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 60,000 | $0 | 639,377 (Direct) | View |
| 2022-12-20 Exercise | 2022-12-22 4:42 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 16,926 | $23.03 | 105,768 (Direct) | View |
| 2022-12-20 Exercise | 2022-12-22 4:42 pm | N/A 2031-09-22 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 16,926 | $0 | 105,768 (Direct) | View |
| 2022-12-15 Exercise | 2022-12-19 7:22 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 1,597 | $23.03 | 124,591 (Direct) | View |
| 2022-12-15 Exercise | 2022-12-19 7:22 pm | N/A 2031-09-22 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 1,597 | $0 | 124,591 (Direct) | View |
| 2022-12-12 Exercise | 2022-12-14 8:56 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 16,256 | $23.03 | 142,144 (Direct) | View |
| 2022-12-12 Exercise | 2022-12-14 8:56 pm | N/A 2031-09-22 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 16,256 | $0 | 142,144 (Direct) | View |
| 2022-11-15 Exercise | 2022-11-16 6:45 pm | N/A 2031-09-22 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 8,125 | $0 | 21,875 (Direct) | View |
| 2022-11-15 Exercise | 2022-11-16 6:45 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 8,125 | $14 | 21,875 (Direct) | View |
| 2022-06-21 Ownership | 2022-06-24 5:23 pm | N/A 2032-06-21 | Viridian Therapeutics Inc. | VRDN | Melvin Carrie COO | 0 | $0 | 210,000 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 07:30 am | N/A 2032-06-08 | Viridian Therapeutics Inc. | VRDN | Moses Jennifer K. Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 07:30 am | N/A 2032-06-08 | Viridian Therapeutics Inc. | VRDN | Kiselak Tomas Director | 12,500 | $0 | 12,500 (Indirect) | View |
| 2022-06-08 Option Award | 2022-06-10 07:30 am | N/A 2032-06-08 | Viridian Therapeutics Inc. | VRDN | Harwin Peter Evan Director | 12,500 | $0 | 12,500 (Indirect) | View |
| 2022-06-08 Option Award | 2022-06-10 07:30 am | N/A 2032-06-08 | Viridian Therapeutics Inc. | VRDN | Morris Arlene Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2022-02-02 Option Award | 2022-02-03 6:15 pm | N/A 2032-02-02 | Viridian Therapeutics Inc. | VRDN | Humer Kristian CFO and CBO | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-02-02 Option Award | 2022-02-03 6:13 pm | N/A 2032-02-02 | Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer | 110,000 | $0 | 110,000 (Direct) | View |
| 2022-02-02 Option Award | 2022-02-03 6:12 pm | N/A 2032-02-02 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 6:11 pm | N/A 2032-02-02 | Viridian Therapeutics Inc. | VRDN | Violin Jonathan Chief Executive Officer | 280,000 | $0 | 880,905 (Direct) | View |
| 2021-12-31 Option Award | 2022-01-03 4:16 pm | N/A 2031-12-31 | Viridian Therapeutics Inc. | VRDN | Humer Kristian CFO and CBO | 121,371 | $0 | 121,371 (Direct) | View |
| 2021-12-08 Conversion | 2021-12-10 6:08 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Violin Jonathan See Remarks | 636,977 | $0 | 630,905 (Direct) | View |
| 2021-10-01 Ownership | 2021-10-04 6:38 pm | N/A 2031-01-18 | Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary | 0 | $0 | 109,500 (Direct) | View |
| 2021-08-16 Ownership | 2021-08-26 1:08 pm | N/A N/A | Viridian Therapeutics Inc. | VRDN | Frazier Life Sciences Public Fund L.P. FHMLSP L.L.C. FHMLSP L.P. 10% Owner | 0 | $0 | 1,305,200 (Direct) | View |
| 2021-07-26 Option Award | 2021-07-27 5:02 pm | N/A 2031-07-26 | Viridian Therapeutics Inc. | VRDN | Humer Kristian CFO and CBO | 360,000 | $0 | 360,000 (Direct) | View |
| 2021-07-14 Option Award | 2021-07-15 4:24 pm | N/A 2031-07-14 | Viridian Therapeutics Inc. | VRDN | Moses Jennifer K. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-16 6:34 pm | N/A 2031-06-03 | Viridian Therapeutics Inc. | VRDN | Kiselak Tomas Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-16 6:27 pm | N/A 2031-06-03 | Viridian Therapeutics Inc. | VRDN | Morris Arlene Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-16 6:26 pm | N/A 2031-06-03 | Viridian Therapeutics Inc. | VRDN | Harwin Peter Evan Director | 12,500 | $0 | 12,500 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-08 5:41 pm | N/A 2031-02-04 | Viridian Therapeutics Inc. | VRDN | TURNER JOSEPH L Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-08 5:40 pm | N/A 2031-02-04 | Viridian Therapeutics Inc. | VRDN | Hatfield Jeffrey S. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-08 5:40 pm | N/A 2031-02-04 | Viridian Therapeutics Inc. | VRDN | Harwin Peter Evan Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-08 5:40 pm | N/A 2031-02-04 | Viridian Therapeutics Inc. | VRDN | Kiselak Tomas Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-08 5:38 pm | N/A 2031-02-04 | Viridian Therapeutics Inc. | VRDN | Morris Arlene Director | 25,000 | $0 | 25,000 (Direct) | View |